Combined Typhoid Fever and Hepatitis A Vaccine: Comparison of Immunogenicity and Safety to Concomitant Monovalent Vaccine over 3 Years | Zendy

D. Overbosch | Zendy; François Peyron | Zendy; Nicole Picot | Zendy; Jean-Paul Varichon | Zendy; Rafaele Dumas | Zendy; Laurent Chambonneau | Zendy; Françoise Weber | Zendy

Open Access

Combined Typhoid Fever and Hepatitis A Vaccine: Comparison of Immunogenicity and Safety to Concomitant Monovalent Vaccine over 3 Years

Author(s) -

D. Overbosch,

François Peyron,

Nicole Picot,

Jean-Paul Varichon,

Rafaele Dumas,

Laurent Chambonneau,

Françoise Weber

Publication year - 2006

Publication title -

journal of travel medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.985

H-Index - 59

eISSN - 1708-8305

pISSN - 1195-1982

DOI - 10.2310/7060.2005.12604

Subject(s) - medicine , immunogenicity , typhoid fever , seroconversion , booster dose , hepatitis a vaccine , tolerability , booster (rocketry) , reactogenicity , vaccination , immunology , gastroenterology , antibody , adverse effect , virology , titer , physics , astronomy

The safety and immunogenicity of Viatim, a combined hepatitis A (HA) and typhoid fever (Vi) vaccine, were compared with the monovalent component vaccines up to and 1 month after a booster dose at 3 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research